Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank58
3Y CAGR-68.5%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-68.5%/yr
vs -23.6%/yr prior
Acceleration
-44.9pp
Decelerating
Percentile
P58
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 2.49% |
| Q2 2025 | -5165.73% |
| Q1 2025 | 98.45% |
| Q4 2024 | -7.75% |
| Q3 2024 | 29.17% |
| Q2 2024 | 54.27% |
| Q1 2024 | 42.68% |
| Q4 2023 | 71.33% |
| Q3 2023 | 63.53% |
| Q2 2023 | 20.38% |
| Q1 2023 | 39.16% |
| Q4 2022 | 38.39% |
| Q3 2022 | 79.50% |
| Q2 2022 | 58.67% |
| Q1 2022 | -20.63% |
| Q4 2021 | -61.96% |
| Q3 2021 | -632.48% |
| Q2 2021 | 142.98% |
| Q1 2021 | -1104.79% |
| Q4 2020 | -96.65% |
| Q3 2020 | -58.32% |
| Q2 2020 | 5507.52% |
| Q1 2020 | -93.57% |
| Q4 2019 | -36.70% |
| Q3 2019 | -46.57% |
| Q2 2019 | 190.79% |
| Q1 2019 | -18.64% |
| Q4 2018 | -131.68% |
| Q3 2018 | -254.96% |
| Q2 2018 | 120.63% |
| Q1 2018 | -204.18% |
| Q4 2017 | -44.26% |
| Q3 2017 | -25.53% |
| Q2 2017 | -28.05% |
| Q1 2017 | -24.05% |
| Q4 2016 | -13.58% |
| Q3 2016 | 0.00% |